How Analysts Feel About Medtronic plc (NYSE:MDT)?

Medtronic plc (NYSE:MDT) Logo
Investors sentiment decreased to 1.14 in Q2 2019. Its down 0.30, from 1.44 in 2019Q1. It worsened, as 57 investors sold Medtronic plc shares while 422 reduced holdings. 127 funds opened positions while 417 raised stakes. 1.04 billion shares or 1.39% more from 1.02 billion shares in 2019Q1 were reported.
Tekla Limited Liability reported 480,035 shares. Renaissance Technology Limited Liability Company has invested 0.19% of its portfolio in Medtronic plc (NYSE:MDT). Madison Invest owns 0.53% invested in Medtronic plc (NYSE:MDT) for 306,505 shares. Lawson Kroeker Inv Management Ne owns 0.3% invested in Medtronic plc (NYSE:MDT) for 9,193 shares. Amp Capital Limited stated it has 668,970 shares. Personal Advsrs accumulated 0% or 2,209 shares. 123,287 are owned by Meeder Asset Mgmt. Highlander Capital Mgmt Limited Liability holds 13,356 shares or 0.79% of its portfolio. Geode Mngmt Lc holds 17.90M shares or 0.42% of its portfolio. Jupiter Asset Mgmt has 6,438 shares. Moreover, Nomura Inc has 0.01% invested in Medtronic plc (NYSE:MDT) for 27,440 shares. Zurcher Kantonalbank (Zurich Cantonalbank) invested 0.64% of its portfolio in Medtronic plc (NYSE:MDT). Round Table Services Ltd Limited Liability Company holds 0.24% or 7,958 shares in its portfolio. Bokf Na, Oklahoma-based fund reported 58,605 shares. Cap Rech Global Invsts holds 4.36M shares.

Medtronic plc (NYSE:MDT) Ratings Coverage

Among 9 analysts covering Medtronic (NYSE:MDT), 6 have Buy rating, 0 Sell and 3 Hold. Therefore 67% are positive. Medtronic has $12200 highest and $84 lowest target. $112.56’s average target is 2.59% above currents $109.72 stock price. Medtronic had 16 analyst reports since March 18, 2019 according to SRatingsIntel. As per Wednesday, August 21, the company rating was maintained by Barclays Capital. The stock of Medtronic plc (NYSE:MDT) has “Hold” rating given on Wednesday, August 21 by Stifel Nicolaus. The stock of Medtronic plc (NYSE:MDT) has “Outperform” rating given on Wednesday, August 21 by Wells Fargo. The stock of Medtronic plc (NYSE:MDT) earned “Hold” rating by Morgan Stanley on Tuesday, June 25. Morgan Stanley maintained Medtronic plc (NYSE:MDT) on Wednesday, August 14 with “Equal-Weight” rating. The stock has “Market Perform” rating by Wells Fargo on Thursday, April 4. Deutsche Bank maintained the shares of MDT in report on Monday, August 19 with “Buy” rating. The firm has “Equal-Weight” rating given on Wednesday, August 21 by Morgan Stanley. The stock of Medtronic plc (NYSE:MDT) has “Outperform” rating given on Wednesday, June 5 by Wells Fargo. The firm has “Outperform” rating by Raymond James given on Wednesday, August 21. Below is a list of Medtronic plc (NYSE:MDT) latest ratings and price target changes.

21/08/2019 Broker: Stifel Nicolaus Rating: Hold Old Target: $95.0000 New Target: $112.0000 Maintain
21/08/2019 Broker: Wells Fargo Rating: Outperform Old Target: $110.0000 New Target: $120.0000 Maintain
21/08/2019 Broker: BMO Capital Markets Rating: Outperform Old Target: $107.0000 New Target: $118.0000 Maintain
21/08/2019 Broker: Barclays Capital Rating: Overweight Old Target: $110 New Target: $117.0000 Maintain
21/08/2019 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $105.0000 New Target: $111.0000 Maintain
21/08/2019 Broker: UBS Rating: Buy Old Target: $112.0000 New Target: $122.0000 Maintain
21/08/2019 Broker: Raymond James Rating: Outperform Old Target: $105.0000 New Target: $118.0000 Maintain
19/08/2019 Broker: Deutsche Bank Rating: Buy Old Target: $100.0000 New Target: $111 Maintain
14/08/2019 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $100.0000 New Target: $105.0000 Maintain
25/06/2019 Broker: Morgan Stanley Rating: Hold New Target: $100 Maintain

The stock decreased 0.59% or $0.65 during the last trading session, reaching $109.72. About 4.14M shares traded. Medtronic plc (NYSE:MDT) has risen 14.44% since September 13, 2018 and is uptrending. It has outperformed by 14.44% the S&P500.

Medtronic plc manufactures and sells device medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company has market cap of $147.22 billion. The companyÂ’s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It has a 33.62 P/E ratio. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases.

More notable recent Medtronic plc (NYSE:MDT) news were published by: Globenewswire.com which released: “Medtronic Reports First Quarter Financial Results NYSE:MDT – GlobeNewswire” on August 20, 2019, also Finance.Yahoo.com with their article: “Medtronic, Other Medtech Providers Could Face Additional Tariffs – Yahoo Finance” published on September 03, 2019, Globenewswire.com published: “Medtronic Announces Planned Leadership Succession NYSE:MDT – GlobeNewswire” on August 28, 2019. More interesting news about Medtronic plc (NYSE:MDT) were released by: Seekingalpha.com and their article: “Reimbursement for Medtronic insulin pump established in Germany – Seeking Alpha” published on September 09, 2019 as well as Forbes.com‘s news article titled: “Why Did Medtronic’s Stock Grow 20% Over The Last 2 Years? – Forbes” with publication date: August 21, 2019.

Medtronic plc (NYSE:MDT) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.